Submission of Annual Secretarial Compliance Report for the Financial Year ended 31st March, 2025.
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anuh Pharma Ltd has submitted its Annual Secretarial Compliance Report for the financial year ended 31 March 2025, as required under Regulation 24A of SEBI LODR Regulations. The report, issued by Pramod S. Shah & Associates, Company Secretaries, confirms that the company complied with all applicable SEBI regulations, secretarial standards, insider trading norms, and disclosure requirements during the year. No director disqualifications were found, and no material non-compliances or SEBI/stock exchange actions were reported against the company. One observation was noted: BSE had raised a query regarding Regulation 18(1) of SEBI LODR (Audit Committee composition), to which the company replied clarifying there was no non-compliance and filed an application seeking withdrawal of any fines, which is currently pending with BSE.
This is a routine annual compliance filing with no material adverse findings, so it is unlikely to move the stock. The pending BSE fine matter related to Audit Committee compliance is a minor regulatory point worth monitoring but does not impact the company's operations.